Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Straus

Showing results (51-60 of 215) with videos related to

Pageof 22
Sort By:
Expert Review of Anticancer Therapy|March 1, 2006
Treatment of Burkitt lymphoma in adultsJohn Gerecitano, David J Straus
Cancer|October 1, 1988
Primary lymphoma of the spleen. Clinical features and outcome after splenectomyJ Kehoe, D J Straus
JAMA Oncology|November 26, 2015
Radiation Therapy for Hodgkin Lymphoma--Can It Be Administered More Safely if Necessary?David J Straus, Oren Cahlon
Cancer Chemotherapy Reports|February 1, 1972
Increased lifespan using the priming dose schedule design in carbazilquinone (NSC-134679) treatment of mouse leukemia L1210M J Straus, A Goldin
Analytical and Quantitative Cytology|December 1, 1983
Labeling indices of human lung cancer. Correlation with histologic type and survivalR E Moran, M J Straus
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 3, 2006
The role of PET in lymphomaYuliya S Jhanwar, David J Straus
Journal of Oncology Practice|November 28, 2012
Clinical guidelines, the politics of value, and the practice of medicine: physicians at the crossroadsRichard A Cooper, David J Straus
Disability and Rehabilitation|December 17, 2019
The potential contribution of critical theories in healthcare transition research and practiceElizabeth J Straus, Helen J Brown
Cell and Tissue Kinetics|September 1, 1978
Dose-dependent cytokinetic changes following 1-beta-D-arabinofuranosylcytosine and hydroxyurea in L1210 and S-180 in vivoM J Straus, R E Moran
Laboratory Animal Science|October 1, 1980
A method for establishing prolonged intravenous infusions in miceR E Moran, M J Straus
Pageof 22

Showing results (51-60 of 215) with videos related to

Sort By:
Pageof 22
Expert Review of Anticancer Therapy|March 1, 2006
Treatment of Burkitt lymphoma in adultsJohn Gerecitano, David J Straus
Cancer|October 1, 1988
Primary lymphoma of the spleen. Clinical features and outcome after splenectomyJ Kehoe, D J Straus
JAMA Oncology|November 26, 2015
Radiation Therapy for Hodgkin Lymphoma--Can It Be Administered More Safely if Necessary?David J Straus, Oren Cahlon
Cancer Chemotherapy Reports|February 1, 1972
Increased lifespan using the priming dose schedule design in carbazilquinone (NSC-134679) treatment of mouse leukemia L1210M J Straus, A Goldin
Analytical and Quantitative Cytology|December 1, 1983
Labeling indices of human lung cancer. Correlation with histologic type and survivalR E Moran, M J Straus
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 3, 2006
The role of PET in lymphomaYuliya S Jhanwar, David J Straus
Journal of Oncology Practice|November 28, 2012
Clinical guidelines, the politics of value, and the practice of medicine: physicians at the crossroadsRichard A Cooper, David J Straus
Disability and Rehabilitation|December 17, 2019
The potential contribution of critical theories in healthcare transition research and practiceElizabeth J Straus, Helen J Brown
Cell and Tissue Kinetics|September 1, 1978
Dose-dependent cytokinetic changes following 1-beta-D-arabinofuranosylcytosine and hydroxyurea in L1210 and S-180 in vivoM J Straus, R E Moran
Laboratory Animal Science|October 1, 1980
A method for establishing prolonged intravenous infusions in miceR E Moran, M J Straus
Pageof 22